European practitioners will gain new methods for treatment after the June meeting of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) where the panel recommended several novel drug candidates and new indications for existing drugs.
Celgene's gene therapy Abecma (idecabtagene vicleucel) was for example nominated for conditional marketing authorization as a fourth-line therapy for bone marrow cancer. CHMP also had a positive view of Biomarin's Voxzogo (vosoritid) for the day-to-day treatment of children with achondroplasia. This drug might eventually challenge Transcon CNP, which is produced by Danish biotech firm Ascendis, if the latter reaches the market.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Analysis Chemist for Quality Control in Orifarm Manufacturing Viminco 
Senior Manager, QA GMP - Genmab 
Bioinformatician / Immunoinformatician - Vaccibody 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck 
KLIFO is looking for an experienced and skilled Proposal Manager for one of our offices in Denmark, Sweden or Germany 
Medical Scientific Liaison Dermo aesthetic, IBSA 
Project Manager, Adcendo ApS 
Senior Clinical Research Specialist - Ambu 
Medical Director (diabetes and obesity) - Zealand Pharma 
Analytical Coordinator - Symphogen 
Evaxion Biotech Careers 
Principal Scientist, Protein Drug Discovery & Development - Y-mAbs Therapeutics A/S 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo